Skip to main content
. Author manuscript; available in PMC: 2026 May 23.
Published in final edited form as: J Gastroenterol Hepatol. 2025 May 23;40(8):1919–1925. doi: 10.1111/jgh.17015

Table 2.

Logistic regression analysis for factors associated with prevalence of cardiovascular disease, cirrhosis, chronic kidney disease and Type II diabetes mellitus by BMI categorya

BMI category Any cardiovascular disease Coronary artery disease Peripheral artery disease Cerebrovascular accident Congestive heart failure Cirrhosis Chronic Kidney Disease stage ≥ 3 Type II DM
OR
(95 % CI)a
p value OR
(95 % CI)
p value OR
(95 % CI)
p value OR
(95 % CI)
p value OR
(95 % CI)
p value OR
(95 % CI)
p value OR (95 % CI) p Value OR (95 % CI)b p Value
Lean Referent Referent Referent Referent Referent Referent Referent Referent
Overweight 0.88 (0.80–0.97) <0.01 0.88 (0.80–0.97) <0.01 0.82 (0.74–0.91) <0.01 0.69 (0.61–0.76) <0.01 0.74 (0.67–0.83) <0.01 1.22 (1.01–1.47) <0.01 0.96 (0.86–1.08) 0.53 0.86 (0.79–0.93) <0.01
Obesity class I 0.86 (0.79–0.95) <0.01 0.86 (0.79–0.95) <0.01 0.72 (0.65–0.80) <0.01 0.61 (0.55–0.68) <0.01 0.75 (0.67–0.83) <0.01 1.35 (1.12–1.63) <0.01 1.06 (0.94–1.18) 0.35 1.17 (1.09–1.27) <0.01
Obesity class II – III 0.86 (0.78–0.94) <0.01 0.86 (0.78–0.94) <0.01 0.63 (0.57–0.70) <0.01 0.52 (0.55–0.68) <0.01 1.14 (1.03–1.26) 0.01 1.58 (1.31–1.89) <0.01 1.17 (1.05–1.30) <0.01 1.95 (1.81–2.10) <0.01
Non-Lean * 0.87 (0.81–0.94) <0.01 0.87 (0.80–0.94) <0.01 0.72 (0.65–0.79) <0.01 0.60 (0.54–0.66) <0.01 0.89 (0.81–0.98) 0.02 1.40 (1.17–1.67) <0.01 1.07 (0.96–1.18) 0.22 1.32 (1.23–1.42) <0.01

Abbreviations: CI, confidence interval; OR, odds ratio.

a

OR adjusted for age, sex, race, smoking status, hypertension, dyslipidemia, DM, and aspirin and statin use.

b

For Type II DM, OR was adjusted with the same confounders excluding DM

*

non-lean analysis was performed using a different model